Previous 10 | Next 10 |
2023-07-23 05:45:00 ET Summary Novartis has signed a $1 billion deal to acquire DTx Pharma - DTx Pharma shareholders will receive $500 million upfront and up to $500 million in milestones. Sichuan Kelun-Biotech completed a $174 million IPO on the Hong Kong Exchange, valuing the co...
2023-07-23 04:43:02 ET Summary Shares of precision oncology concern Day One Biopharmaceuticals, Inc. are down over 50% from their 2023 high as Novartis’ combination therapy received first approval for pLGG. However, its lead candidate (tovorafenib) has the potential to trea...
2023-07-21 11:17:38 ET Chinese biotech BeiGene ( NASDAQ: BGNE ) said that its drug tislelizumab has received a positive opinion from an advisory committee of the European Medicines Agency for the treatment of advanced or metastatic esophageal squamous cell carcinoma after platinum-b...
2023-07-19 12:58:12 ET Summary Swiss pharmaceutical group Novartis raised its full-year earnings forecast due to strong first half performance and plans a share buyback of up to $15 billion by 2025. The company also announced the separation of its generic drugs unit, Sandoz, throu...
2023-07-18 16:11:49 ET Novartis (NYSE: NVS) enjoyed a strong rally today, as the Swiss drugmaker announced an improved revenue forecast for 2023 and a massive share repurchase program. Specifically, the drugmaker's stock rose by as much as 5.1% on heavy volume during the morning por...
2023-07-18 15:17:27 ET Summary Novartis AG Q2 2023 earnings topped Wall Street expectations on both the top and bottom lines. A $15 billion share buyback was announced and is expected to be completed by year end 2025. Novartis has several drugs in its pipeline, which should ca...
2023-07-18 15:00:28 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2023 Earnings Call Jul 18, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2023 Earnings Call Transcript
2023-07-18 13:13:08 ET Novartis AG (NVS) Q2 2023 Earnings Conference Call July 18, 2023, 8:00 AM ET Company Participants Samir Shah - Global Head, Investor Relations Vas Narasimhan - Chief Executive Officer Harry Kirsch - Chief Financial Officer Conference ...
2023-07-18 12:50:52 ET After closing down ~23% Monday from its opening price that day, Apellis Pharmaceuticals ( NASDAQ: APLS ) is off another 25% in Tuesday afternoon trading. The biopharma is still reeling from the aftermath of reports of significant eye inflammation s...
2023-07-18 08:50:04 ET Novartis' ( NYSE: NVS ) board said that it would initiate a buyback of up to $15B worth of shares by the end of 2025 as the Swiss drugmaker also boosted its 2023 sales guidance. Both items were revealed during Novartis' ( NVS ) Q2 financial results in ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...